IceCure Medical Ltd.(ICCM)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

IceCure Medical Ltd. (ICCM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ICCM at 17.7/100 on a 32-signal composite quality model, placing it at rank #2,821 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), IceCure Medical Ltd. reports quarterly revenue of $3.4M, net income of $-15.1M, free cash flow of $-14.6M. Top institutional holders of ICCM by reported 13-F value include ARMISTICE CAPITAL, UBS Group AG, Concurrent Investment Advisors, based on the most recent SEC filings. ICCM trades on the Nasdaq exchange and files with the SEC under CIK 1584371. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ICCM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for IceCure Medical Ltd. directly from SEC EDGAR.